Orally Bioavailable 4-Phenoxy-quinoline Compound as a Potent Aurora Kinase B Relocation Blocker for Cancer Treatment
Authors:
- 21 July 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 6 (8) , 1155-1163
Abstract
We investigated a novel 4-phenoxy-quinoline-based scaffoldthatmislocalizes the essential mitotic kinase, Aurora kinase B (AURKB).Here, we evaluated the impact of halogen substitutions (F, Cl, Br,and I) on this scaffold with respect to various drug parameters. Br-substituted LXY18 was found to be a potent and orally bioavailable disruptorof cell division, at sub-nanomolar concentrations. LXY18 prevents cytokinesis by blocking AURKB relocalization in mitosisand exhibits broad-spectrum antimitotic activity in vitro. With afavorable pharmacokinetic profile, it shows widespread tissue distributionincluding the blood-brain barrier penetrance and effectiveaccumulation in tumor tissues. More importantly, it markedly suppressestumor growth. The novel mode of action of LXY18 may eliminatesome drawbacks of direct catalytic inhibition of Aurora kinases. Successfuldevelopment of LXY18 as a clinical candidate for cancertreatment could enable a new, less toxic means of antimitotic attackthat avoids drug resistance mechanisms.Keywords
Funding Information
- Anticancer Bioscience (2016)
This publication has 14 references indexed in Scilit:
- Looking Back, Looking Forward at Halogen Bonding in Drug DiscoveryMolecules, 2017
- An overview of quinoline as a privileged scaffold in cancer drug discoveryExpert Opinion on Drug Discovery, 2017
- The chromosomal passenger complex (CPC) as a key orchestrator of orderly mitotic exit and cytokinesisFrontiers in Cell and Developmental Biology, 2015
- Definition of the halogen bond (IUPAC Recommendations 2013)Pure and Applied Chemistry, 2013
- Tumor heterogeneity and its implication for drug deliveryJournal of Controlled Release, 2012
- The chromosomal passenger complex (CPC): from easy rider to the godfather of mitosisNature Reviews Molecular Cell Biology, 2012
- Activation of tyrosine kinases by mutation of the gatekeeper threonineNature Structural & Molecular Biology, 2008
- Aurora Kinases: New Targets for Cancer TherapyClinical Cancer Research, 2006
- Halogenation of Drugs Enhances Membrane Binding and PermeationChemBioChem, 2004
- Mitotic kinases as regulators of cell division and its checkpointsNature Reviews Molecular Cell Biology, 2001